Ross A - Search Results

1

Can we stop prostate specific antigen testing 10 years after radical prostatectomy?

Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, Walsh PC. Loeb S, et al. Among authors: ross a. J Urol. 2011 Aug;186(2):500-5. doi: 10.1016/j.juro.2011.03.116. Epub 2011 Jun 15. J Urol. 2011. PMID: 21679999 Free PMC article.

2

Benign prostate glands at the bladder neck margin in robotic vs open radical prostatectomy.

Loeb S, Epstein JI, Ross AE, Schultz L, Humphreys EB, Jarow JP. Loeb S, et al. BJU Int. 2010 May;105(10):1446-9. doi: 10.1111/j.1464-410X.2010.09336.x. Epub 2010 Mar 25. BJU Int. 2010. PMID: 20346031

3

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.

Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC. Ross AE, et al. J Clin Oncol. 2010 Jun 10;28(17):2810-6. doi: 10.1200/JCO.2009.25.7311. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439642

4

Gene expression pathways of high grade localized prostate cancer.

Ross AE, Marchionni L, Vuica-Ross M, Cheadle C, Fan J, Berman DM, Schaeffer EM. Ross AE, et al. Prostate. 2011 Oct 1;71(14):1568-77. doi: 10.1002/pros.21373. Epub 2011 Feb 25. Prostate. 2011. PMID: 21360566

5

A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.

Pierorazio PM, Ross AE, Schaeffer EM, Epstein JI, Han M, Walsh PC, Partin AW. Pierorazio PM, et al. J Urol. 2011 May;185(5):1691-7. doi: 10.1016/j.juro.2010.12.059. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419448 Free PMC article.

6

Molecular effects of genistein on male urethral development.

Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, Salmasi AH, Schaeffer AJ, Gearhart JP, Schaeffer EM. Ross AE, et al. J Urol. 2011 May;185(5):1894-8. doi: 10.1016/j.juro.2010.12.095. Epub 2011 Mar 21. J Urol. 2011. PMID: 21421236 Free PMC article.

7

Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer.

Pierorazio PM, Ross AE, Han M, Epstein JI, Partin AW, Schaeffer EM. Pierorazio PM, et al. BJU Int. 2012 Apr;109(7):988-93. doi: 10.1111/j.1464-410X.2011.10514.x. Epub 2011 Aug 22. BJU Int. 2012. PMID: 21880104 Free PMC article.

8

Management of primary squamous cell carcinoma at the mucocutaneous junction of an ileal conduit.

Gupta AD, Bandari J, Ross AE, McCall CM, Tufaro AP, Bivalacqua TJ. Gupta AD, et al. Urology. 2011 Dec;78(6):1229-31. doi: 10.1016/j.urology.2011.07.1385. Epub 2011 Sep 10. Urology. 2011. PMID: 21908020 No abstract available.

9

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.

Ross AE, Feng Z, Pierorazio PM, Landis P, Walsh PC, Carter HB, Trock BJ, Schaeffer EM. Ross AE, et al. BJU Int. 2012 Sep;110(5):651-7. doi: 10.1111/j.1464-410X.2011.10875.x. Epub 2012 Jan 30. BJU Int. 2012. PMID: 22289613 Free PMC article.

10

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM. Pierorazio PM, et al. BJU Int. 2012 Oct;110(8):1122-8. doi: 10.1111/j.1464-410X.2012.10986.x. Epub 2012 Feb 28. BJU Int. 2012. PMID: 22373045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,974 results

Search Page